Chemical | Study No. | Vehicle | Species | Site | Membrane | Area (cm2) | Cell Type | Exposure Time (h) | Length of Study(h) | % Recovery | % Penetrated | % Absorbed | s-s-flux (mcrg/cm2/h) | kp (cm/h) | n | Lag Time (h) | Ref.No |
2,4 Dimethylamine | 742 | Commercial Formulation Clean Crop | Rat | Back | Dermatomed to 0.3mm | 0.64 | Flow-through | 24 | 48 | 95.6 | 26.5 | 8.3 | 3 | | 4 | | 93 |
2,4 Dimethylamine | 743 | Commercial Formulation Wilbur-Ellis | Rat | Back | Dermatomed to 0.3mm | 0.64 | Flow-through | 24 | 48 | 96.8 | 21.4 | 5.8 | 3 | | 4 | | 93 |
2,4 Dimethylamine | 744 | Commercial Formulation Clean Crop | Guinea pig | Back | Dermatomed to 0.3mm | 0.64 | Flow-through | 24 | 48 | 100.3 | 16.9 | 7.5 | 3.6 | | 4 | | 93 |
2,4 Dimethylamine | 745 | Commercial Formulation Wilbur-Ellis | Guinea pig | Back | Dermatomed to 0.3mm | 0.64 | Flow-through | 24 | 48 | 95.8 | 12.8 | 5.9 | 3.6 | | 4 | | 93 |
2,4 Dimethylamine | 746 | Commercial Formulation Clean-Crop | Human | Abdomen | Dermatomed to 0.3mm | 0.64 | Flow-through | 24 | 48 | 97 | 20.9 | 10.3 | 9.2 | | 4 | | 93 |
2,4 Dimethylamine | 747 | Commercial Formulation Wilbur-Ellis | Human | Abdomen | Dermatomed to 0.3mm | 0.64 | Flow-through | 24 | 48 | 94.6 | 21.8 | 10.9 | 7.9 | | 4 | | 93 |
Previous Next |